Ed Cara

The specialized ink could eventually replace clunky EEG wires and "potentially revolutionize" brain-computer interface devices.

The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD flare-ups seen in 50 years, following new promising clinical trial data.

We asked a health law expert about what to expect in the coming years: "It is critical that people exercise good judgment in the sources of their information to protect themselves."

New data collected by the FDA has found that montelukast can bind to brain cells, which may explain the risk of mental health adverse effects linked to its use.

A study of 14,000 WeightWatchers participants is the latest to suggest that Ozempic and similar obesity drugs could be adapted into treatments for substance use disorders.

Cassava Sciences' simufilam failed a Phase III trial for Alzheimer's disease, likely marking the end of a drug surrounded by allegations of poorly done and fraudulent research.

Grocery stores across the country have been experiencing egg shortages recently, thanks in no small part to bird flu.

An international group of experts has agreed that low dose oral minoxidil, the active ingredient in Rogaine, can be a safe and effective treatment for hair loss, but doubts persist.

A new meta-analysis by researchers in Finland finds that athletes tend to have better working memory than others.

The hair-raising case is an example of the rare condition known as Rapunzel syndrome.